NRX Pharmaceuticals
NRXP
NRXP
30 hedge funds and large institutions have $1.86M invested in NRX Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 8 closing their positions.
Holders
30
Holders Change
-4
Holders Change %
-11.76%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
4
Closed
8
Calls
$58K
Puts
–
Net Calls
+$58K
Net Calls Change
+$17K
Top Buyers
1 |
AI
1
AdvisorShares Investments
Bethesda,
Maryland
|
$296K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$21.5K |
3 |
3
Morgan Stanley
New York
|
$40.8K |
4 |
4
Renaissance Technologies
New York
|
$92K |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$7.73K |